Investigación e Informes

Celltrion will attend the 2026 Bio International Convention in San Diego, presenting its AI‑based drug discovery platform and next‑generation pipeline to expand beyond biosimilars.

Acelra, the new‑drug subsidiary of Jonggeundang, reported Phase 1 data for its CETP inhibitor ACL‑508, aimed at lowering LDL‑C and raising HDL‑C, at the NLA annual meeting in Chicago.

The National Health Insurance Service (NHIS) of Korea has begun building a public electronic prescription delivery system, a key infrastructure for formalizing telemedicine.

A recent Inje University study finds generative AI rapidly spreading in health education, with limited current use in pharmacy curricula but growing interest among universities and practicing pharmacists.

Inofutics secured a support agreement for its IPS101A Parkinson’s gene therapy, now part of Korea’s 2026 national new drug development project, aiming to complete Phase 1 and obtain Phase 2 approval within two years.

Korea’s BioTech Research Association urged a national pipeline intelligence system covering vaccines and therapeutics, discussed at a Jeju University seminar on pandemic preparedness.

Boehringer Ingelheim Korea and KMI Korean Medical Institute have signed an MOU to conduct real‑world evidence research on liver health in obese and metabolic disease patients using health‑check data.

On the 18th, Korea Oganon held the Fertility POWER Symposium in Seoul, sharing the latest clinical insights on infertility treatment as part of its 2026 Oganon Week program.

SK Biopharm has signed a joint R&D agreement with AI-driven Insilico Medicine to develop CNS therapeutics, focusing on neuroimmune targets, announced at the 2026 Bio International Convention.

Pharmacist Han Hyun‑ji and AI researcher Kim Jung‑hyun will host a free webinar on the 25th at 9 PM, demonstrating Claude’s features and paper‑search techniques for pharmacists.

Generative AI advances such as Vibe Coding are driving a push for digital literacy in pharmacy, with major conferences highlighting AI‑enabled pharmacy management and counseling.

A randomized trial of 64 adults shows Nordic walking reduces depressive symptoms within five weeks, especially in severe cases.